INOZYME PHARMA, INC. Cash
INOZYME PHARMA, INC. had Cash of $29.10 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2025-05-14
- 2025-03-31: Cash $29.10M.
- 2024-12-31: Cash $91.90M.
- 2023-12-31: Cash $70.70M.
| Period end | Cash |
|---|---|
| 2025-03-31 | $29.10M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $91.90M 10-K · filed 2025-03-10 |
| 2023-12-31 | $70.70M 10-K · filed 2025-03-10 |